Mucosal host defence response to hysterectomy assessed by saliva analyses: A comparison of propofol and isoflurane anaesthesia

Anaesthesia

Volumn 53, Issue 11, 1998, Pages 1067-1073

  Lahteenmaki M ^a   Salo, M ^b   Tenovuo, J ^c  

^a SATAKUNTA CENTRAL HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Anaesthetics, intravenous, propofol; Anaesthetics, volatile, isoflurane; Immune response, IgA, IgG, IgM, nonimmunoglobulin defence factors

Indexed keywords

AMYLASE; ANESTHETIC AGENT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ISOFLURANE; LYSOZYME; MYELOPEROXIDASE; PEROXIDASE; PROPOFOL; PROTEIN; SALIVA PROTEIN; THIOCYANATE;

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HOST RESISTANCE; HUMAN; HYSTERECTOMY; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MUCOSA; RANDOMIZED CONTROLLED TRIAL; SALIVA ANALYSIS; SALIVATION;

ADULT; AGED; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; FEMALE; HUMANS; HYSTERECTOMY; IMMUNITY, MUCOSAL; IMMUNOGLOBULINS; ISOFLURANE; MIDDLE AGED; MOUTH MUCOSA; PROPOFOL; SALIVA; SALIVATION;

EID: 0031730386     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.1998.00529.x     Document Type: Article

References (24)

1. Lähteenmäki M, Tenovuo J, Salo M, Perttilä J. Effects of open heart surgery on oral mucous host defence systems. Acta Anaesthesiologica Scandinavica 1997; 41: 837-42.
2. Mestecky J. Saliva as a manifestation of the common mucosal system. Annals of the New York Academy of Sciences 1993; 29: 184-194.
3. Kullaa-Mikkonen A, Tenovuo J, Sorvari T. Changes in composition of whole saliva in patients with fissured tongue. Scandinavian Journal of Dental Research 1985; 93: 522-8.
4. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265-75.
5. Betts RH, Dainton FS. Electron transfer and other processes involved in the spontaneous bleaching of acidified solutions of ferric thiocyanate. Journal of the American Chemistry Society 1953; 75: 5721-7.
6. Wever R, Kast WM, Kasinoedin JH, Boelens R. The peroxidation of thiocyanate catalysed by myeloperoxidase and lactoperoxidase. Biochemica et Biophysica Acta 1982; 709: 212-9.
7. Tenovuo J, Lehtonen OP, Aaltonen AS, Vilja P, Tuohimaa P. Antimicrobial factors in whole saliva in human infants. Infection and Immunity 1986; 51: 49-53.
8. Månsson-Rahemtulla B, Baldone DC, Pruitt KM, Rahemtulla F. Specific assays tor peroxidases in human saliva. Archives of Oral Biology 1986; 31: 661-8.
9. Lehtonen OP, Gråhn E, Ståhlberg T, Laitinen LA. Amount and avidity of salivary and serum antibodies against Streptococcus mutans in two groups of human subjects with different dental caries susceptibility. Infection and Immunity 1984; 43: 308-13.
10. Pirttikangas C-O, Salo M, Peltola O. Propofol infusion anaesthesia and the immune response in elderly patients undergoing ophthalmic surgery. Anaesthesia 1996; 51: 1056-61.
11. Salo M, Pirttikangas C-O, Pulkki K. Effects of propofol emulsion and thiopentone on T helper cell type-1/type-2 balance in vitro. Anaesthesia 1997; 52: 341-4.
12. Cullen PM, Turtle M, Prys-Roberts C, Way WL, Due J. Effect of propofol anesthesia on baroreflex activity in humans. Anesthesia and Analgesia 1987; 66: 115-20.
13. Yli-Hankala A, Randell T, Seppälä T, Lindgren L. Increases in hemodynamic variables and catecholamine levels after rapid increase in isoflurane concentration. Anesthesiology 1993; 78: 266-71.
14. Arglebe C. Biochemistry of human saliva. Advances in Oto-Rhino-Laryngology 1981; 26: 97-234.
15. Schubert MM, Izutsu KT. Iatrogenic causes of salivary gland dysfunction. Journal of Dental Research 1987; 66: 680-8.
16. Valdez IH, Fox PC. Diagnosis and management of salivary dysfunction. Critical Reviews in Oral Biology and Medicine 1993; 4: 271-7.
17. Mandel I. Sialochemistry in diseases and clinical situations affecting salivary glands. Critical Reviews in Clinical Laboratory Sciences 1980; 12: 321-36.
18. Mirakhur RK, Dundee JW. Glycopyrrolate: pharmacology and clinical use. Anaesthesia 1983; 38: 1195-204.
19. Brandzaeg P. Salivary immunoglobulins. In: Tenovuo J, ed. Human Saliva: Clinical Chemistry and Microbiology, Vol. II. Boca Raton, FL: CRC Press, Inc., 1989: 3-15.
20. Salo M. Effects of anaesthesia and surgery on the immune response. Acta Anaesthesiologica Scandinavica 1992; 36: 201-20.
21. Bortner C, Miller R, Arnold R. Effects of α-amylase on in vitro growth of Legionella pneumophila. Infection and Immunity 1983; 41: 44-9.
22. Tenovuo J. Nonimmunoglobulin defense factors in human saliva. In: Tenovuo J, ed. Human Saliva: Clinical Chemistry and Microbiology, Vol. II. Boca Raton, FL: CRC Press, Inc., 1989: 57-8.
23. Smith QT, Yang CH. Salivary myeloperoxidase of young adult humans. Proceedings of the Society for Experimental Biology and Medicine 1984; 175: 468-75.
24. Tenovuo J, Gråhn E, Lehtonen OP, Hyyppä T, Karhuvaara L, Vilja P. Antimicrobial factors in saliva: ontogeny and relation to oral health. Journal of Dental Research 1987; 66: 475-9.